| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $384.6M | -1.9% |
| Cost of Revenue | $295.4M | -3.5% |
| Gross Profit | $89.2M | +4.1% |
| R&D Expense | $4.3M | -2.3% |
| SG&A Expense | $49.1M | +2.1% |
| Operating Income | $24.0M | -20.3% |
| Pre-tax Income | $22.2M | -16.2% |
| Income Tax | $9.1M | +11.0% |
| Net Income | $7.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.3M | +102.4% |
| Accounts Receivable | $44.6M | -2.6% |
| Inventory | $92.4M | +10.5% |
| Current Assets | $164.0M | -6.7% |
| Total Assets | $369.7M | -3.3% |
| Current Liabilities | $98.2M | +4.8% |
| Long-term Debt | $39.4M | -12.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.0M | -33.5% |
| Capital Expenditures | $7.8M | -24.3% |
| Investing Cash Flow | -$5.1M | -50.0% |
| Financing Cash Flow | -$25.0M | +43.2% |
| Free Cash Flow | $26.2M | -35.8% |
| -58.2% |
| EPS (Basic) | $0.29 | -58.0% |
| EPS (Diluted) | $0.28 | -58.8% |
| Total Liabilities |
| $143.3M |
| -12.0% |
| Stockholders' Equity | $226.4M | +3.1% |